Sahajanand Medical Technologies (SMT), through its Italian partner Eukon, has signed an agreement with Emilia Romagna region in Italy to deliver approximately 10,000 Supraflex in the next two years.

This agreement was signed after Supraflex DES won against 9 other DES after 8 months of technical and economical evaluations during the regional tender process concluded few weeks ago. The tender process evaluated the products on basis of quality as well as price offerings from Boston Scientific, Biotronik, Biosensor, Cardinal Health, Envision, Eucatech, Meril and Terumo.

Gennaro Broya de Lucia, Sole Director of Eukon said, “The partnership with SMT gave us all the ammunition to step in to a difficult market segment where an extremely fine balance in required between the needs of the interventional cardiologists, who only ask for top quality devices, and the national healthcare system, whose focus is to decrease the health care costs.”.

SMT’s Head of Western Europe Gaurav Goel commented: “It’s the first time in Europe that an Indian driven team has proven its mettle against the established DES companies. We are in sync with the necessities of the current generation of operators and are agile and innovative. Just like our product Supraflex, we are more ‘flexible’ and we are fully ready to build on this important milestone to boost to our expansion in Italy and rest of Europe”.

Emilia Romagna is one of the most populous regions of North Italy, with 15 cath labs performing the 10% of the Italian PTCA, listing cities like: Bologna, Ferrara, Modena, Parma, Piacenza, Rimini, Forlì, Ravenna and Reggio Emilia.

Supraflex, the 3rd generation DES from SMT, has the lowest strut (60µm) thickness among all the available sirolimus eluting coronary stents, without compromising radial strength. It comes with the broadest sizes range currently available for PTCA, a safety proven bio absorbable polymer and an optimized drug release.

These features, the continuous clinical outcomes and a great post-sales support are making Supraflex, the choice of a growing family of hemodynamists.

Eukon is a medical devices company in Italy since 2004. The company represent high end solutions in the radiology and interventional cardiology field. Its key products are: NIRS/IVUS coronary imaging system by InfraredX Inc, Boston US; “QFR” a novel FFR computation system from standard angiography images produced by Medis Bv., Leiden, The Nederland; Myrian advanced oncology analysis platform by Intrasense, Montpellier, France and Supraflex “DES” by SMT

Established in the year 1998, SMT became the first indigenous player in India to successfully launch coronary stent. SMT is also the first company to get CE approval for DES with Biodegradable Polymers in the world. It is India's largest stent manufacturing company and sells its product in more than 60 countries across the world.